Answers are grounded in this paper and cite their sources.
Systematic review demonstrates favorable evidence for Pfizer-BioNTech vaccination in adolescents aged 12–15 years, supporting expanded COVID-19 prevention guidelines.
In May 2021, after a systematic review of all available data, the Advisory Committee on Immunization Practices made an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12–15 years for the prevention of COVID-19.
No takes yet. Share an insight, caveat, or question.
Wallace et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: